Global Next-Generation Sequencing Data Analysis Market Size, Status and Forecast 2021-2027
- April 2021
- 126 pages
Next-Generation Sequencing Data Analysis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Next-Generation Sequencing Data Analysis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Segment by Application
Hospitals & Clinics
Pharma & Biotech Entities
Rest of Europe
Rest of Asia
Rest of Latin America
Middle East & Africa
Rest of MEA
Thermo Fisher Scientific, Inc.
F. Hoffmann-La Roche Ltd.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Intrexon Bioinformatics Germany GmbH
Pacific Biosciences of California, Inc.
Fabric Genomics, Inc.
SciGenom Labs Pvt. Ltd.
Golden Helix, Inc.
The Beijing Genomics Institute
Da An Gene
Product Type & Applications
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- F. Hoffmann-La Roche Ltd.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Intrexon Bioinformatics Germany GmbH
- Partek, Inc.
- Eurofins Scientific
- Pacific Biosciences of California, Inc.
- DNASTAR, Inc.
- Next-Generation Sequencing Data Analysis
- Academic Research
- Clinical Research
- Hospitals & Clinics
- Pharma & Biotech Entities
- Other Users
Have query on this report?Make an Enquiry
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next-Generation Sequencing Data Analysis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
Table 1. Global Next-Generation Sequencing Data Analysis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of In-house
Table 3. Key Players of Outsourced
Table 4. Global Next-Generation Sequencing Data Analysis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Next-Generation Sequencing Data Analysis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Healthcare
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017